← All indications
Hepatitis C
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Subtype terms (1)
More specific conditions that are subtypes of Hepatitis C in the MeSH hierarchy.
- Hepatitis C, Chronic
242 drugs (106 approved, 136 experimental)
Drugs by status
Approved for this indication (16)
Phase 4 trials (46)
- ezetimibe
- efavirenz
- vitamin d3
- orlistat
- maraviroc
- citalopram
- daclizumab
- elbasvir
- folic acid
- tacrolimus
- tenofovir
- cyanocobalamin
- lamivudine
- atazanavir
- atorvastatin
- daclatasvir
- ribavirin
- rifaximin
- sitagliptin
- sirolimus
- cyclosporine
- mycophenolate
- buprenorphine
- everolimus
- fosamprenavir
- emtricitabine
- boceprevir
- pibrentasvir
- zidovudine
- bictegravir
- +16 more
Phase 3 trials (33)
- al-335
- alisporivir
- betaine
- faldaprevir
- epoetin
- prednisone
- eltrombopag
- escitalopram
- amantadine
- leucovorin
- miglyol oil
- narlaprevir
- nitazoxanide
- peginterferon lambda-1a
- ravidasvir
- lopinavir
- l-epigallocatechin
- zinc dichloride
- methadone
- natural anti-hemolytic
- silymarin
- rilpivirine
- cobicistat
- elvitegravir
- thymalfasin
- interferon beta-1b
- interferon gamma-1b
- furaprevir
- yimitasvir
- odalavir
- +3 more
Phase 2 trials (60)
- bms-986094
- thalidomide
- ach-0137171
- sovaprevir
- adefovir dipivoxil
- setrobuvir
- avi-4065
- bavituximab
- sorafenib
- bzf961
- candesartan
- pri-724
- fluvastatin
- cts-1027
- filibuvir
- sertraline
- gs-9256
- nivocasan
- hydroxychloroquine
- nesbuvir
- rosuvastatin
- il-7
- nivolumab
- mericitabine
- Merimepodib
- miravirsen
- mtl-cebpa
- nov-205
- omega interferon
- tegobuvir
- +30 more
Phase 1 trials (64)
Other trials (21)
- metformin
- metronidazole
- acetylcysteine
- procaine benzylpenicillin
- bicyclol
- paroxetine
- betamethasone
- entecavir
- fluorodopa
- dolutegravir
- icosapent ethyl
- nevirapine
- vitamin c
- sun mushroom
- live attenuated varicella vaccine
- clarithromycin
- esomeprazole
- tetracycline
- hepatitis-a virus (inactivated) / hepatitis-b surface antigen
- favipiravir
- mare milk
Organizations
Organization Involved with Phase 4 Indications (255)
- Kyungpook University
- Riyadh Military Hospital
- Yale University
- University of Bonn
- Government of Canada
- University of Washington
- City of San Francisco
- Government of Thailand
- University of Barcelona
- National Taiwan University
- Kyoto University
- Fundacion SEIMC-GESIDA
- Tabriz Medical University
- Konkuk University
- Icahn School of Medicine at Mount Sinai
- Cornell University
- National Institute of Allergy and Infectious Diseases (NIAID)
- Ev. Krankenhaus Essen-Werden
- Ahvaz Jundishapur University of Medical Sciences
- University of California, San Francisco
- University of Southern California
- University of Sao Paulo
- AmFAR
- University of Ottawa
- Cheongju St. Mary's Hospital
- Hospital Universitario Fundación Alcorcón
- Government of Mexico
- St. James's Hospital, Dublin
- SC Liver Research Consortium, LLC
- Mansoura University
- +225 more
Organization Involved with Phase 3 Indications (158)
- Utrecht University
- Government of Belarus
- Egyptian Railway Hospital
- Tel Aviv University
- Institute Of Cardiology & Internal Diseases, Kazakhstan
- Sheikh Zayed Medical College
- Institut Pasteur
- Kirov Military Medical Academy
- Radboud University
- University of Lyon
- Medipoint Hospitals Pvt. Ltd.
- Selayang Hospital, Selangor
- Tianjin Second People's Hospital
- NUCLIMED
- Ontario HIV Treatment Network
- University of Tokyo
- Debiopharm
- Suez Canal University
- Peking University
- Bakhtar Bioshimi Co
- TCM Biotech International Corp.
- Iran Hepatitis Network
- Ghazza University
- Government of Malaysia
- BioGeneric Pharma
- Ortho Biotech, Inc.
- China Medical University
- Universidad de Cordoba
- Erasmus University Rotterdam
- Egyptian Liver Hospital
- +128 more
Organization Involved with Phase 2 Indications (134)
- Wake Forest University
- Valneva
- MTmedical Institute of Health
- BioWest Therapeutics Inc
- Elan Pharmaceuticals
- Veterans Medical Research Foundation
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Flamel Technologies
- Ghaem Gastrointestinal Clinic
- New England Research Institutes
- BioLineRx, Ltd.
- Azienda Ospedaliera Universitaria Policlinico
- Santaris Pharma A/S
- Amarillo Biosciences, Inc.
- Conatus Pharmaceuticals
- The Cleveland Clinic
- ViroChem Pharma
- Metropolitan Research
- ZymoGenetics
- University of Birmingham
- MassBiologics
- Avid Bioservices
- Lundbeck
- Hebrew University
- Cedars-Sinai Medical Center
- Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
- United Therapeutics
- Atlanta Gastroenterology Associates
- University of Groningen
- IQVIA
- +104 more
Organization Involved with Phase 1 Indications (46)
- Transition Therapeutics
- GeneOne Life Science
- Wycombe Hospital, High Wycombe, Buckinghamshire
- XTL Biopharmaceuticals
- Alamo Medical Research
- Bach & Godofsky, MD, PA
- European Commission
- Dynavax Technologies Corporation
- Bio-Manguinhos
- WCCT Global
- Synteract, Inc.
- Eiger BioPharmaceuticals
- Sandoz
- Medical University of Warsaw
- Impact Clinical Trials
- Case Western Reserve University
- Epoch Biosciences
- Pevion Biotech Ltd
- Theravance
- Temple University
- Tower Cancer Research Foundation
- Quest Clinical Research
- Genentech
- Microbio Co Ltd
- Virobay Inc.
- iTherX Pharmaceuticals Inc.
- Akros
- GeneCure Biotechnologies
- Spring Bank Pharmaceuticals, Inc.
- University of Liverpool
- +16 more
Organization Involved with Other Experimental Indications (28)
- Reliant Pharmaceuticals
- University of Kansas
- Ram Manohar Lohia Insitute of Medical Sciences
- Charles University
- Postgraduate Institute of Medical Education and Research
- Organization to Achieve Solutions in Substance Abuse
- State Department of Health of Rio Grande do Sul
- Sao Paulo State University
- University of Missouri, Kansas City
- Hillel Yaffe Medical Center
- Asfendiyarov Kazakh National Medical University
- Government of Brazil
- Medical University of Graz
- West Virginia University
- Saint Luke's Health System
- Zagazig University
- Frontier Research Institute
- Parexel
- University of Arizona
- Corporal Michael J. Crescenz VA Medical Center
- Government of Punjab, India
- Eurasia Invest Ltd., Kazakhstan
- Government of Kazakhstan
- Bar Ilan University
- Julius-Maximilians University
- Aarhus University
- Truman Medical Center
- American College of Gastroenterology